Rotavirus vaccines: Update on global impact and future priorities

Human Vaccines

Volumn 7, Issue 12, 2011, Pages 1282-1290

  Yen, Catherine ^a,b   Tate, Jacqueline E ^b   Patel, Manish M ^b   Cortese, Margaret M ^b   Lopman, Benjamin ^b   Fleming, Jessica ^c   Lewis, Kristen ^c   Jiang, Baoming ^b   Gentsch, Jon ^b   Steele, Duncan ^c   Parashar, Umesh D ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c PATH   (United States)

Author keywords

Gastroenteritis; Rotavirus; Rotavirus vaccines; Vaccine impact; Vaccines

Indexed keywords

ROTAVIRUS VACCINE;

CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; HUMAN; IMMUNOREACTIVITY; INFECTION PREVENTION; INFECTIOUS DIARRHEA; INTUSSUSCEPTION; MASS IMMUNIZATION; NONHUMAN; POSTMARKETING SURVEILLANCE; REVIEW; ROTAVIRUS; ROTAVIRUS INFECTION; TREATMENT DURATION; VACCINE PRODUCTION; VIRAL GASTROENTERITIS; VIRUS SHEDDING; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

CHILD, PRESCHOOL; DEVELOPING COUNTRIES; GASTROENTERITIS; HUMANS; IMMUNIZATION PROGRAMS; INFANT; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION;

EID: 84855165809     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.7.12.18321     Document Type: Review

References (97)

1. Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009; 200:9-15; PMID:19817620; http://dx.doi.org/10.1086/605025.
2. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9:565-72; PMID:12737740; http://dx.doi.org/10.3201/eid0905.020562.
3. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22; PMID:16394298; http://dx.doi.org/10.1056/NEJMoa052434.
4. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33; PMID:16394299; http://dx.doi.org/10.1056/NEJMoa052664.
5. Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:606-14; PMID:20692030; http://dx.doi.org/10.1016/S0140-6736(10)60889-6.
6. Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:615-23; PMID:20692031; http://dx.doi.org/10.1016/S0140-6736(10)60755-6.
7. Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289-98; PMID:20107214; http://dx.doi.org/10.1056/NEJMoa0904797.
8. World Health Organization. Meeting of the Global Advisory Committee on Vaccine Safety, December 2010. Wkly Epidemiol Rec 2011; 86:38-43; PMID:21299033.
9. Greenberg HB, Estes MK. Rotaviruses: from pathogenesis to vaccination. Gastroenterology 2009; 136:1939-51; PMID:19457420; http://dx.doi.org/10.1053/j. gastro.2009.02.076.
10. Estes MK, Kapikian AZ. Rotaviruses. In: Knipe DM, Howley PM, Eds. Field's Virology. Philadelphia, Pennsylvania: Lippincott, Willliams & Wilkins 2007.
11. Gentsch JR, Laird AR, Bielfelt B, Griffin DD, Banyai K, Ramachandran M, et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 2005; 192:146-59; PMID:16088798; http://dx.doi.org/10.1086/431499.
12. Gentsch JR, Woods PA, Ramachandran M, Das BK, Leite JP, Alfieri A, et al. Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. J Infect Dis 1996; 174:30-6; PMID:8752288; http://dx.doi.org/10.1093/infdis/174.Supplement-1.S30.
13. Matthijnssens J, Bilcke J, Ciarlet M, Martella V, Banyai K, Rahman M, et al. Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol 2009; 4:1303-16; PMID:19995190; http://dx.doi.org/10.2217/fmb.09.96.
14. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005; 15:29-56; PMID:15484186; http://dx.doi.org/10.1002/rmv.448.
15. Kang G, Arora R, Chitambar SD, Deshpande J, Gupte MD, Kulkarni M, et al. Multicenter, hospital-based surveillance of rotavirus disease and strains among indian children aged <5 years. J Infect Dis 2009; 200:147-53; PMID:19817593; http://dx.doi.org/10.1086/605031.
16. Linhares AC, Stupka JA, Ciapponi A, Bardach AE, Glujovsky D, Aruj PK, et al. Burden and typing of rotavirus group A in Latin America and the Caribbean: systematic review and meta-analysis. Rev Med Virol 2011; 21:89-109; PMID:21384462; http://dx.doi.org/10.1002/rmv.682.
17. Sanchez-Padilla E, Grais RF, Guerin PJ, Steele AD, Burny ME, Luquero FJ. Burden of disease and circulating serotypes of rotavirus infection in sub-Saharan Africa: systematic review and meta-analysis. Lancet Infect Dis 2009; 9:567-76; PMID:19695493; http://dx.doi.org/10.1016/S1473-3099(09)70179-3.
18. Todd S, Page NA, Duncan Steele A, Peenze I, Cunliffe NA. Rotavirus strain types circulating in Africa: Review of studies published during 1997-2006. J Infect Dis 2010; 202:34-42; PMID:20684715; http://dx.doi.org/10.1086/653555.
19. Ansari SA, Springthorpe VS, Sattar SA. Survival and vehicular spread of human rotaviruses: possible relation to seasonality of outbreaks. Rev Infect Dis 1991; 13:448-61; PMID:1866549; http://dx.doi.org/10.1093/clinids/13.3.448.
20. Butz AM, Fosarelli P, Dick J, Cusack T, Yolken R. Prevalence of rotavirus on high-risk fomites in day-care facilities. Pediatrics 1993; 92:202-5; PMID:8393172.
21. Pickering LK, Bartlett AV, Woodward WE. Acute infectious diarrhea among children in day care: epidemiology and control. Rev Infect Dis 1986; 8:539-47; PMID:3529310; http://dx.doi.org/10.1093/clinids/8.4.539.
22. Bishop RF. Natural history of human rotavirus infection. Arch Virol Suppl 1996; 12:119-28; PMID:9015109.
23. Black RE, Lopez de Romana G, Brown KH, Bravo N, Bazalar OG, Kanashiro HC. Incidence and etiology of infantile diarrhea and major routes of transmission in Huascar, Peru. Am J Epidemiol 1989; 129:785-99; PMID:2646919.
24. Kovacs A, Chan L, Hotrakitya C, Overturf G, Portnoy B. Serum transaminase elevations in infants with rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1986; 5:873-7; PMID:3794904; http://dx.doi.org/10.1097/00005176-198611000- 00008.
25. Mata L, Simhon A, Padilla R, del Mar Gamboa M, Vargas G, Hernandez F, et al. Diarrhea associated with rotaviruses, enterotoxigenic Escherichia coli, Campylobacter, and other agents in Costa Rican children 1976-1981. Am J Trop Med Hyg 1983; 32:146-53; PMID:6337517.
26. Rodriguez WJ, Kim HW, Arrobio JO, Brandt CD, Chanock RM, Kapikian AZ, et al. Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young children. J Pediatr 1977; 91:188-93; PMID:195031; http://dx.doi.org/10.1016/S0022-3476(77)80810-X.
27. Staat MA, Azimi PH, Berke T, Roberts N, Bernstein DI, Ward RL, et al. Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J 2002; 21:221-7; PMID:12005086; http://dx.doi.org/10.1097/ 00006454-200203000-00012.
28. Matson DO. Rotaviruses. In: Long SS, Pickering LK, Prober CG, Eds. Principles and Practice of Pediatric Infectious Diseases. New York, NY: Churchill Livingstone 2003.
29. Dickey M, Jamison L, Michaud L, Care M, Bernstein DI, Staat MA. Rotavirus meningoencephalitis in a previously healthy child and a review of the literature. Pediatr Infect Dis J 2009; 28:318-21; PMID:19258926; http://dx.doi.org/10.1097/INF.0b013e31818ddbe9.
30. Gilger MA, Matson DO, Conner ME, Rosenblatt HM, Finegold MJ, Estes MK. Extraintestinal rotavirus infections in children with immunodeficiency. J Pediatr 1992; 120:912-7; PMID:1317419; http://dx.doi.org/10.1016/S0022-3476(05) 81959-6.
31. Bines JE, Liem NT, Justice FA, Son TN, Kirkwood CD, de Campo M, et al. Risk factors for intussusception in infants in Vietnam and Australia: adenovirus implicated, but not rotavirus. J Pediatr 2006; 149:452-60; PMID:17011313; http://dx.doi.org/10.1016/j.jpeds.2006.04.010.
32. Konno T, Suzuki H, Kutsuzawa T, Imai A, Katsushima N, Sakamoto M, et al. Human rotavirus infection in infants and young children with intussusception. J Med Virol 1978; 2:265-9; PMID:212529; http://dx.doi.org/10.1002/jmv.1890020310.
33. Peter G, Myers MG. Intussusception, rotavirus and oral vaccines: summary of a workshop. Pediatrics 2002; 110:67; PMID:12456934; http://dx.doi.org/10. 1542/peds.110.6.e67.
34. Blutt SE, Conner ME. Rotavirus: to the gut and beyond! Curr Opin Gastroenterol 2007; 23:39-43; PMID:17133083; http://dx.doi.org/10.1097/MOG. 0b013e328011829d.
35. Blutt SE, Kirkwood CD, Parreno V, Warfield KL, Ciarlet M, Estes MK, et al. Rotavirus antigenaemia and viraemia: a common event? Lancet 2003; 362:1445-9; PMID:14602437; http://dx.doi.org/10.1016/S0140-6736(03)14687-9.
36. Fischer TK, Ashley D, Kerin T, Reynolds-Hedmann E, Gentsch J, Widdowson MA, et al. Rotavirus antigenemia in patients with acute gastroenteritis. J Infect Dis 2005; 192:913-9; PMID:16088842; http://dx.doi.org/10.1086/432549.
37. Liakopoulou E, Mutton K, Carrington D, Robinson S, Steward CG, Goulden NJ, et al. Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogeneic bone marrow transplantation. Bone Marrow Transplant 2005; 36:691-4; PMID:16113671; http://dx.doi.org/10.1038/sj.bmt. 1705127.
38. Rayani A, Bode U, Habas E, Fleischhack G, Engelhart S, Exner M, et al. Rotavirus infections in paediatric oncology patients: a matched-pairs analysis. Scand J Gastroenterol 2007; 42:81-7; PMID:17190767; http://dx.doi.org/10.1080/ 00365520600842179.
39. Saulsbury FT, Winkelstein JA, Yolken RH. Chronic rotavirus infection in immunodeficiency. J Pediatr 1980; 97:61-5; PMID:6247473; http://dx.doi.org/10. 1016/S0022-3476(80)80131-4.
40. Stelzmueller I, Dunst KM, Hengster P, Wykypiel H, Steurer W, Wiesmayr S, et al. A cluster of rotavirus enteritis in adult transplant recipients. Transpl Int 2005; 18:470-4; PMID:15773970; http://dx.doi.org/10.1111/j.1432-2277.2004. 00073.x.
41. Steele AD, Cunliffe N, Tumbo J, Madhi SA, De Vos B, Bouckenooghe A. A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children. J Infect Dis 2009; 200:57-62; PMID:19817615; http://dx.doi.org/10.1086/605027.
42. Cunliffe NA, Gondwe JS, Kirkwood CD, Graham SM, Nhlane NM, Thindwa BD, et al. Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children. Lancet 2001; 358:550-5; PMID:11520526; http://dx.doi.org/10.1016/S0140-6736(01)05706-3.
43. Jere C, Cunliffe NA, Hoffman IF, Stewart PW, Kilaru R, Broadhead RL, et al. Plasma HIV burden in Malawian children co-infected with rotavirus. AIDS 2001; 15:1439-42; PMID:11504968; http://dx.doi.org/10.1097/00002030-200107270- 00016.
44. Gurwith M, Wenman W, Hinde D, Feltham S, Greenberg H. A prospective study of rotavirus infection in infants and young children. J Infect Dis 1981; 144:218-24; PMID:6268713; http://dx.doi.org/10.1093/infdis/144.3.218.
45. Velázquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996; 335:1022-8; PMID:8793926; http://dx.doi.org/10.1056/NEJM199610033351404.
46. Levy K, Hubbard AE, Eisenberg JN. Seasonality of rotavirus disease in the tropics: a systematic review and meta-analysis. Int J Epidemiol 2009; 38:1487-96; PMID:19056806; http://dx.doi.org/10.1093/ije/dyn260.
47. Bahl R, Ray P, Subodh S, Shambharkar P, Saxena M, Parashar U, et al. Incidence of severe rotavirus diarrhea in New Delhi, India, and G and P types of the infecting rotavirus strains. J Infect Dis 2005; 192:114-9; PMID:16088794; http://dx.doi.org/10.1086/431497.
48. Cunliffe NA, Kilgore PE, Bresee JS, Steele AD, Luo N, Hart CA, et al. Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization. Bull World Health Organ 1998; 76:525-37; PMID:9868844.
49. Centers for Disease Control and Prevention. Rotavirus surveillance - worldwide, 2009. MMWR Morb Mortal Wkly Rep 2011; 60:514-6; PMID:21527889.
50. Fischer TK, Valentiner-Branth P, Steinsland H, Perch M, Santos G, Aaby P, et al. Protective immunity after natural rotavirus infection: a community cohort study of newborn children in Guinea-Bissau, west Africa. J Infect Dis 2002; 186:593-7; PMID:12195345; http://dx.doi.org/10.1086/342294.
51. Moulton LH, Staat MA, Santosham M, Ward RL. The protective effectiveness of natural rotavirus infection in an American Indian population. J Infect Dis 1998; 178:1562-6; PMID:9815204; http://dx.doi.org/10.1086/314504.
52. Ward RL, Bernstein DI. Protection against rotavirus disease after natural rotavirus infection. US Rotavirus Vaccine Efficacy Group. J Infect Dis 1994; 169:900-4; PMID:8133107; http://dx.doi.org/10.1093/infdis/169.4.900.
53. De Mol P, Zissis G, Butzler JP, Mutwewingabo A, Andre FE. Failure of live, attenuated oral rotavirus vaccine. Lancet 1986; 2:108; PMID:2873370; http://dx.doi.org/10.1016/S0140-6736(86)91643-0.
54. Hanlon P, Hanlon L, Marsh V, Byass P, Shenton F, Hassan-King M, et al. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet 1987; 1:1342-5; PMID:2884455; http://dx.doi.org/10.1016/S0140-6736(87) 90649-0.
55. Lanata CF, Black RE, del Aguila R, Gil A, Verastegui H, Gerna G, et al. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. J Infect Dis 1989; 159:452-9; PMID:2536789; http://dx.doi.org/10.1093/ infdis/159.3.452.
56. Vesikari T. Clinical trials of live oral rotavirus vaccines: the Finnish experience. Vaccine 1993; 11:255-61; PMID:8382419; http://dx.doi.org/10.1016/ 0264-410X(93)90026-T.
57. Vesikari T, Isolauri E, Delem A, d'Hondt E, Andre FE, Beards GM, et al. Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J Pediatr 1985; 107:189-94; PMID:3894608; http://dx.doi.org/10.1016/S0022-3476(85)80123-2.
58. Vesikari T, Isolauri E, D'Hondt E, Delem A, Andre FE, Zissis G. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet 1984; 1:977-81; PMID:6143964; http://dx.doi.org/10.1016/S0140-6736(84)92323-7.
59. Tate JE, Patel MM, Steele AD, Gentsch JR, Payne DC, Cortese MM, et al. Global impact of rotavirus vaccines. Expert Rev Vaccines 2010; 9:395-407; PMID:20370550; http://dx.doi.org/10.1586/erv.10.17.
60. Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group. JAMA 1995; 273:1191-6; PMID:7707626; http://dx.doi.org/10.1001/jama.273.15.1191.
61. Joensuu J, Koskenniemi E, Pang XL, Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 1997; 350:1205-9; PMID:9652561; http://dx.doi.org/10.1016/S0140-6736(97)05118-0.
62. Perez-Schael I, Garcia D, Gonzalez M, Gonzalez R, Daoud N, Perez M, et al. Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. J Med Virol 1990; 30:219-29; PMID:2160516; http://dx.doi.org/10.1002/jmv.1890300315.
63. Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME, Zito ET, et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines - report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group. Pediatrics 1996; 97:7-13; PMID:8545227.
64. Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine - United States 1998-1999. MMWR Morb Mortal Wkly Rep 1999; 48:577-81; PMID:10428095.
65. Kramarz P, France EK, Destefano F, Black SB, Shinefield H, Ward JI, et al. Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J 2001; 20:410-6; PMID:11332666; http://dx.doi.org/10.1097/00006454- 200104000-00008.
66. Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001; 344:564-72; PMID:11207352; http://dx.doi.org/10.1056/NEJM200102223440804.
67. Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370:1757-63; PMID:18037080; http://dx.doi.org/10. 1016/S0140-6736(07)61744-9.
68. Phua KB, Lim FS, Lau YL, Nelson EA, Huang LM, Quak SH, et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine 2009; 27:5936-41; PMID:19679216; http://dx.doi.org/10.1016/j.vaccine.2009.07.098.
69. Kawamura N, Tokoeda Y, Oshima M, Okahata H, Tsutsumi H, Van Doorn LJ, et al. Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life. Vaccine 2011; 29: http://dx.doi.org/10.1016/j. vaccine.2011.05.017; PMID:21640780.
70. Linhares AC, Velazquez FR, Perez-Schael I, Saez- Llorens X, Abate H, Espinoza F, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008; 371:1181-9; PMID:18395579; http://dx.doi.org/10. 1016/S0140-6736(08)60524-3.
71. Correia JB, Patel MM, Nakagomi O, Montenegro FM, Germano EM, Correia NB, et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis 2010; 201:363-9; PMID:20047501; http://dx.doi.org/10.1086/649843.
72. do Carmo GM, Yen C, Cortes J, Siqueira AA, de Oliveira WK, Cortez-Escalante JJ, et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med 2011; 8:1001024; PMID:21526228; http://dx.doi.org/10.1371/journal.pmed. 1001024.
73. de Palma O, Cruz L, Ramos H, de Baires A, Villatoro N, Pastor D, et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 2010; 340:2825; PMID:20551120; http://dx.doi.org/10.1136/bmj.c2825.
74. Yen C, Armero Guardado JA, Alberto P, Rodriguez Araujo DS, Mena C, Cuellar E, et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J 2011; 30:6-10; PMID:21048524; http://dx.doi.org/10.1097/INF. 0b013e3181fefa05.
75. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano CM, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 2010; 362:299-305; PMID:20107215; http://dx.doi.org/10.1056/NEJMoa0905211.
76. Quintanar-Solares M, Yen C, Richardson V, Esparza-Aguilar M, Parashar UD, Patel MM. Impact of rotavirus vaccination on diarrhea-related hospitalizations among children <5 years of age in Mexico. Pediatr Infect Dis J 2011; 30:11-5; PMID:21183834; http://dx.doi.org/10.1097/INF.0b013e3181fefb32.
77. Patel M, Pedreira C, De Oliveira LH, Tate J, Orozco M, Mercado J, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009; 301:2243-51; PMID:19491186; http://dx.doi.org/10.1001/jama.2009.756.
78. Molto Y, Cortes JE, De Oliveira LH, Mike A, Solis I, Suman O, et al. Reduction of diarrhea-associated hospitalizations among children aged <5 Years in Panama following the introduction of rotavirus vaccine. Pediatr Infect Dis J 2011; 30:16-20; PMID:21183835; http://dx.doi.org/10.1097/INF. 0b013e3181fefc68.
79. Boom JA, Tate JE, Sahni LC, Rench MA, Quaye O, Mijatovic-Rustempasic S, et al. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J 2010; 29:1133-5; PMID:20634776; http://dx.doi.org/10.1097/INF. 0b013e3181ed18ab.
80. Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E, Parashar UD. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis 2010; 201:1617-24; PMID:20402596; http://dx.doi.org/10. 1086/652403.
81. Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children. Pediatr Infect Dis J 2010; 29:319-23; PMID:19935446.
82. Braeckman T, Van Herck K, Raes M, Vergison A, Sabbe M, Van Damme P. Rotavirus vaccines in Belgium: policy and impact. Pediatr Infect Dis J 2011; 30:21-4; PMID:21183836; http://dx.doi.org/10.1097/INF.0b013e3181fefc51.
83. Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, et al. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule. Pediatr Infect Dis J 2011; 30:25-9; PMID:21183837; http://dx.doi.org/10.1097/INF.0b013e3181fefdee.
84. Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010; 125:199-207; PMID:20083525; http://dx.doi.org/10.1542/peds.2009-1021.
85. Tate JE, Mutuc JD, Panozzo CA, Payne DC, Cortese MM, Cortes JE, et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J 2011; 30:30-4; PMID:21183838; http://dx.doi.org/10.1097/INF.0b013e3181ffe3eb.
86. Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, et al. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011; 29:3061-6; PMID:21316503; http://dx.doi.org/10.1016/j.vaccine.2011.01.088.
87. Patel MM, Lopez-Collada VR, Bulhoes MM, De Oliveira LH, Bautista Marquez A, Flannery B, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 2011; 364:2283-92; PMID:21675888; http://dx.doi.org/10.1056/NEJMoa1012952.
88. Australian Government Therapeutic Goods Administration. Rotavirus vaccination and risk of intussusception. http://www.tga.gov.au/safety/alerts- medicine-rotavirus-110225.htm. Accessed August 24, 2011.
89. Belongia EA, Irving SA, Shui IM, Kulldorff M, Lewis E, Yin R, et al. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J 2010; 29:1-5; PMID:19907356; http://dx.doi.org/10.1097/INF.0b013e3181af8605.
90. Haber P, Patel M, Izurieta HS, Baggs J, Gargiullo P, Weintraub E, et al. Postlicensure monitoring of intus-susception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics 2008; 121:1206-12; PMID:18519491; http://dx.doi.org/10.1542/peds.2007-3793.
91. Levine MM. Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biol 2010; 8:129; PMID:20920375; http://dx.doi.org/10.1186/1741-7007-8-129.
92. Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis 2009; 200:39-48; PMID:19817613; http://dx.doi.org/10.1086/605035.
93. Moon SS, Wang Y, Shane AL, Nguyen T, Ray P, Dennehy P, et al. Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr Infect Dis J 2010; 29:919-23; PMID:20442687; http://dx.doi.org/10.1097/INF. 0b013e3181e232ea.
94. BusinessWire website B. Rotavirus Vaccine Manufacturing Agreement Between BIOVIRx and IDT 2006. http://www.businesswire.com/news/home/20060327005013/en/ Rotavirus-Vaccine-Manufacturing-Agreement-BIOVIRx-IDT. Accessed July 22, 2011.
95. Wang Y, Azevedo M, Saif LJ, Gentsch JR, Glass RI, Jiang B. Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets. Vaccine 2010; 28:5432-6; PMID:20558244; http://dx.doi.org/10.1016/j.vaccine.2010.06.006.
96. GlaxoSmithKline website. Millions of children in the world's poorest countries could receive vaccination against rotavirus diarrhoeal disease under new offer made by GSK to the GAVI Alliance. http://www.gsk.com/media/ pressreleases/2011/2011-pressrelease-462284.htm. Accessed July 22, 2011.
97. GAVI Alliance website. Donors commit vaccine funding to achieve historic milestone. http://www.gavialliance.org/library/news/press-releases/2011/donors- commit-vaccine-funding-to-achieve-historicmilestone-in-global-health/. Accessed July 22, 2011.